ANAPROX
- Product NDC
- 61919-183
- 11-digit product format
- 619190183
- Labeler code
- 61919
- Product ID
- 61919-183_9c595e63-0913-3358-e053-2995a90a54c4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA078314
- Marketing category
- ANDA
- Marketing start
- 2016-07-11
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 550 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-183-60 | ANAPROX | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-183 | ANAPROX (NAPROXEN SODIUM) TABLET [DIRECT RX] | 2 | Legacy NDC, 1 package rows | 20200128_3784e189-f431-54d2-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-183-60 | 61919018360 | 60 TABLET in 1 BOTTLE (61919-183-60) | 60 tablet | 2016-07-11 | 0000-00-00 | No | No | Current |